Brad Close explains why you shouldn't sit on your patent rights.
Patents are a one-size-fits-all legal right for inventions across every technology field. The varied fields create different legal necessities, so that diverse industries are often at odds over what they attempt to accomplish with patent rights.
This is demonstrated by comparing the industries of bio/pharma with mobile telecoms. With bio/pharma you have the requirement of massive, long-term, front-end investment to develop a few long-lived products that require minimal numbers of patents to protect, whereas mobile telecoms are characterised by an ever-changing environment in which a single product, like a smartphone, can incorporate inventions that are covered by hundreds, if not thousands, of patents.
It is therefore no surprise that strategic licensing plays out differently across different technical fields. With bio/pharma companies, patents tend to be used to exclude all competition on a blockbuster drug. In the mobile telecoms space, however, the “right to exclude” approach is rarely feasible.
To continue reading, you need a subscription to WIPR. Start a subscription to WIPR for £455.
In-house feature articles, the archive and expert comment require a paid subscription. Subscribe now.
Want to give it a try? We are offering a two week free trial to the WIPR website – register and select “Free Trial” to begin access to the full WIPR archive and read the latest news, features and expert comment. Begin your free trial here.
Is your 2 week free trial about to end? Upgrade to a 12 month subscription for £455 now.
If you have already subscribed please login.
If you have any technical issues please email James Lynn on email@example.com.
Patent, Patent litigation, bio, pharma, Motorola,